[eDisclosure Notice] KOSPI - 4 Days

◆ Daewoong Pharmaceutical = On a separate basis, the third quarter operating profit is tentatively estimated at 7.025 billion KRW, an increase of 150.8% compared to the same period last year. Sales for the same period rose 2.7% to 248.921 billion KRW.

◆ Coway = On a consolidated basis, the third quarter operating profit is tentatively estimated at 168.6 billion KRW, an increase of 20.2% compared to the same period last year. Sales for the same period increased 5.4% to 800.4 billion KRW.

◆ BT One = Decided to acquire 3,974,562 shares (5 billion KRW) of Haim Bio to maximize profits through business diversification.

This content was produced with the assistance of AI translation services.